Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA: Onco-Rash for Anti-EGFR Skin Toxicity
NCT04878692Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Randomised trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Measurement of the percentage of Onco-Rash failure by counting the number of patients with a rash grade ≥ 2 (NCI-CTCAE scale) at 6 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04878692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04878692.